Ignite Creation Date:
2024-05-06 @ 12:29 AM
Last Modification Date:
2024-10-26 @ 10:50 AM
Study NCT ID:
NCT01585207
Status:
COMPLETED
Last Update Posted:
2018-01-19
First Post:
2012-04-24
Brief Title:
Proof-of-Concept Safety Study of CPP-109 Vigabatrin for Treatment Refractory Tourettes Disorder
Sponsor:
Barbara J Coffey
Organization:
Icahn School of Medicine at Mount Sinai
Organization Data
Organization:
Icahn School of Medicine at Mount Sinai
Class:
OTHER
Study ID:
GCO 12-0964
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Barbara J Coffey
Lead Sponsor Class:
OTHER
Responsible Party:
Barbara J Coffey
Responsible Party Title:
Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Icahn School of Medicine at Mount Sinai
Old Name:
None
Old Organization:
None